<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37105729</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1478-5242</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>730</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>The British journal of general practice : the journal of the Royal College of General Practitioners</Title><ISOAbbreviation>Br J Gen Pract</ISOAbbreviation></Journal><ArticleTitle>Prognostic factors for persistent fatigue after COVID-19: a prospective matched cohort study in primary care.</ArticleTitle><Pagination><StartPage>e340</StartPage><EndPage>e347</EndPage><MedlinePgn>e340-e347</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3399/BJGP.2022.0158</ELocationID><Abstract><AbstractText Label="BACKGROUND">Persistent fatigue after COVID-19 is common; however, the exact incidence and prognostic factors differ between studies. Evidence suggests that age, female sex, high body mass index, and comorbidities are risk factors for long COVID.</AbstractText><AbstractText Label="AIM">To investigate the prevalence of persistent fatigue after COVID-19 in patients with a mild infection (managed in primary care) during the first wave of the pandemic and to determine prognostic factors for persistent fatigue.</AbstractText><AbstractText Label="DESIGN AND SETTING">This was a prospective cohort study in Dutch general practice, combining online questionnaires with data from electronic health records.</AbstractText><AbstractText Label="METHOD">Patients who contacted their GP between March and May 2020 and were diagnosed with COVID-19 during the first wave of the pandemic were included. Patients were matched to controls without COVID-19 based on age, sex, and GP practice. Fatigue was measured at 3, 6, and 15 months, using the Checklist of Individual Strength.</AbstractText><AbstractText Label="RESULTS">All the participants were GP attendees and included 179 with suspected COVID-19, but who had mild COVID and who had not been admitted to hospital with COVID, and 122 without suspected COVID-19. Persistent fatigue was present in 35% (49/142) of the suspected COVID-19 group and 13% (14/109) of the non-COVID-19 group (odds ratio 3.65; 95% confidence interval = 1.82 to 7.32). Prognostic factors for persistent fatigue included low education level, absence of a partner, high neuroticism (using the Eysenck Personality Questionnaire Revised-Short Form), low resilience, high frequency of GP contact, medication use, and threatening experiences in the past. The latter three factors appeared to be prognostic factors for persistent fatigue specifically after COVID-19 infection.</AbstractText><AbstractText Label="CONCLUSION">GP patients with COVID-19 (who were not admitted to hospital with COVID) have a fourfold higher chance of developing persistent fatigue than GP patients who had not had COVID-19. This risk is even higher in psychosocially vulnerable patients who had COVID-19.</AbstractText><CopyrightInformation>&#xa9; The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>K&#xf6;nig</LastName><ForeName>Benthe H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Jaarsveld</LastName><ForeName>Cornelia Hm</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-4269-0041</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bischoff</LastName><ForeName>Erik Wma</ForeName><Initials>EW</Initials><Identifier Source="ORCID">0000-0002-3323-8475</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schers</LastName><ForeName>Henk J</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0002-9362-9451</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucassen</LastName><ForeName>Peter Lbj</ForeName><Initials>PL</Initials><Identifier Source="ORCID">0000-0003-2955-2119</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olde Hartman</LastName><ForeName>Tim C</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0003-2078-1206</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Gen Pract</MedlineTA><NlmUniqueID>9005323</NlmUniqueID><ISSNLinking>0960-1643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">determinants</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">outpatients</Keyword><Keyword MajorTopicYN="N">persistent fatigue</Keyword><Keyword MajorTopicYN="N">primary healthcare</Keyword><Keyword MajorTopicYN="N">prospective cohort study</Keyword></KeywordList><CoiStatement>The authors have declared no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>21</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37105729</ArticleId><ArticleId IdType="pmc">PMC9926286</ArticleId><ArticleId IdType="doi">10.3399/BJGP.2022.0158</ArticleId><ArticleId IdType="pii">BJGP.2022.0158</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17(9):e1003346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7508369</ArticleId><ArticleId IdType="pubmed">32960881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaswa R, Govender I. Novel coronavirus pandemic: a clinical overview. S Afr Fam Pract. 2020;62(1):e1&#x2013;e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8377866</ArticleId><ArticleId IdType="pubmed">32633997</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, Taylor AK, O&#x2019;Donnell CA, et al. Finding the &#x2018;right&#x2019; GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. 2020. DOI: .</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen P, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2019;7:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6370741</ArticleId><ArticleId IdType="pubmed">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Stormorken E, Jason LA, Kirkevold M. From good health to illness with post-infectious fatigue syndrome: a qualitative study of adults&#x2019; experiences of the illness trajectory. BMC Fam Pract. 2017;18(1):49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5369194</ArticleId><ArticleId IdType="pubmed">28347294</ArticleId></ArticleIdList></Reference><Reference><Citation>Gezondheidsraad . Me/CVS. Den Haag: Gezondheidsraad; 2018.</Citation></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, March&#x2012;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021;11(1):13153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. 2021;27(1):154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss B, L&#xf6;schau M, Seidel T, et al. Are fatigue symptoms and chronic fatigue syndrome following Q fever infection related to psychosocial variables? J Psychosom Res. 2012;72(4):300&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">22405225</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31&#x2013;S34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398292</ArticleId><ArticleId IdType="pubmed">30930717</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Weel C. The Continuous Morbidity Registration Nijmegen: background and history of a Dutch general practice database. Eur J Gen Pract. 2008;14(Suppl 1):5&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">18949638</ArticleId></ArticleIdList></Reference><Reference><Citation>Schers H, van Weel C, van Boven K, et al. The COVID-19 Pandemic in Nijmegen, the Netherlands: changes in presented health problems and demand for primary care. Ann Fam Med. 2021;19(1):44&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7800742</ArticleId><ArticleId IdType="pubmed">33431391</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M, Spruit MA, Burtin C, et al. Fatigue is highly prevalent in patients with asthma and contributes to the burden of disease. J Clin Med. 2018;7(12):471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6306949</ArticleId><ArticleId IdType="pubmed">30477110</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS) Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S263&#x2013;S286.</Citation><ArticleIdList><ArticleId IdType="pubmed">22588750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolster EAM, Balemans ACJ, de Groot V, et al. Fatigue in children and young adults with physical disabilities: relation with energy demands of walking and physical fitness. Pediatr Phys Ther. 2020;32(3):202&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">32604360</ArticleId></ArticleIdList></Reference><Reference><Citation>Deary V, Chalder T, Sharpe M. The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clin Psychol Rev. 2007;27(7):781&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">17822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosmalen JG, Neeleman J, Gans RO, de Jonge P. The association between neuroticism and self-reported common somatic symptoms in a population cohort. J Psychosom Res. 2007;62(3):305&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">17324681</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugha TS, Cragg D. The List of Threatening Experiences: the reliability and validity of a brief life events questionnaire. Acta Psychiatr Scand. 1990;82(1):77&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">2399824</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajesh G, Eriksson M, Pai K, et al. The validity and reliability of the Sense of Coherence Scale among Indian university students. Glob Health Promot. 2016;23(4):16&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">25897012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronis SD, Westphaln KK, Kleinman LC, et al. Performance of the person centered primary care measure in pediatric continuity clinic. Acad Pediatr. 2021;21(6):1077&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222409</ArticleId><ArticleId IdType="pubmed">33359516</ArticleId></ArticleIdList></Reference><Reference><Citation>RStudio Team . RStudio: integrated development environment for R. Boston, MA: RStudio Inc; 2016.</Citation></Reference><Reference><Citation>Selvin S. Statistical analysis of epidemiologic data. Oxford: Oxford University Press; 2004.</Citation></Reference><Reference><Citation>olde Hartman TC, Scheepers TP, Lucassen P, Boven Kv. Do women with severe persistent fatigue present with fatigue at the primary care consultation? Zeitschrift Psychologie. 2020;228(2):93&#x2013;99.</Citation></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic. medRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.03.21252086</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Muratori Holanda T, Alberico C, Rios-Colon L, et al. Trends in COVID-19 health disparities in North Carolina: preparing the field for long-haul patients. Healthcare (Basel) 2021;9(12):1704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8702005</ArticleId><ArticleId IdType="pubmed">34946430</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger Z, Altiery DEJV, Assoumou SA, Greenhalgh T. Long COVID and health inequities: the role of primary care. Milbank Q. 2021;99(2):519&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8241274</ArticleId><ArticleId IdType="pubmed">33783907</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>